Please assess the completion status of the following clinical trial:

Trial Title: SLV308 for Treatment of Patients With Parkinson's Disease Experiencing Motor Fluctuations

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Diagnosis of idiopathic Parkinson's Disease,~* advance stage of disease,~* Modified Hoehn \& Yahr stage II-IV,~* presence of a recognizable 'on' and 'off' state (motor fluctuations) and stable treatment with levodopa for at least 28 days prior to randomization~Exclusion Criteria:~* 'on-off' phenomena or 'yo-yoing' and/or an abrupt unpredictable loss of efficacy unrelated to the timing of L-DOPA administration,~* Prevalent expression of troublesome dyskinesias during 'on' time at waking hours,~* Diagnosis is unclear or a suspicion of other parkinsonian syndromes exists,~* Previous surgery for the treatment of PD

- Gender: ALL
- Minimum Age: 30 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): None
- 2 (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).